Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial

Introduction: Autologous platelet-rich plasma (PRP) and hyaluronic acid (HA) are common treatments for knee osteoarthritis (OA). Several studies have demonstrated PRP as a safe and effective treatment for OA and, in some studies, produces a better outcome than HA. Objective: The primary objective of...

Full description

Bibliographic Details
Main Authors: Eric A. Branch, Joshua J. Cook, Achraf Cohen, Hillary Plummer, Alireza Emami, Jessica Truett, Adam W. Anz
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Cartilage & Joint Preservation
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667254523000343
_version_ 1797398431311855616
author Eric A. Branch
Joshua J. Cook
Achraf Cohen
Hillary Plummer
Alireza Emami
Jessica Truett
Adam W. Anz
author_facet Eric A. Branch
Joshua J. Cook
Achraf Cohen
Hillary Plummer
Alireza Emami
Jessica Truett
Adam W. Anz
author_sort Eric A. Branch
collection DOAJ
description Introduction: Autologous platelet-rich plasma (PRP) and hyaluronic acid (HA) are common treatments for knee osteoarthritis (OA). Several studies have demonstrated PRP as a safe and effective treatment for OA and, in some studies, produces a better outcome than HA. Objective: The primary objective of this study was to determine if HA injected with PRP would improve the efficacy of treatment of symptomatic knee OA compared to PRP alone. We hypothesized that the addition of HA would improve the efficacy of (PRP). Methods: A total of 64 participants with Kellgren-Lawrence (KL) Grades 1 to 4 knee OA were randomized into 2 groups and scheduled to receive 3-injections. Group 1 [PRP] received injections of PRP. Group 2 [HA+PRP] received the same treatment, with an additional HA injection for the first 2 injections. Both groups were blindfolded for the first 2 injections. To evaluate the efficacy of the regimen, participants completed patient reported outcome measures (PROMs). PROMs were completed prior to injections and at 1, 3, 6, 12, 18, and 24 months after the final injection. Results: Participants in both groups felt pain consistent with standard-of-care HA injection regimens with no difference in perceived pain. No infections or complications were observed. All PROM scores demonstrated improvement over baseline from 1-24 months post injections. There were no statistically significant differences between the groups. Conclusions: For the treatment of OA, PRP alone or PRP concomitantly with HA performed similarly out to 24 months. PRP in combination with HA was not superior to PRP alone.
first_indexed 2024-03-09T01:25:28Z
format Article
id doaj.art-8869d1ed1d1543dcb5ec6dc0bc3ceb4c
institution Directory Open Access Journal
issn 2667-2545
language English
last_indexed 2024-03-09T01:25:28Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Journal of Cartilage & Joint Preservation
spelling doaj.art-8869d1ed1d1543dcb5ec6dc0bc3ceb4c2023-12-10T06:18:55ZengElsevierJournal of Cartilage & Joint Preservation2667-25452023-12-0134100129Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trialEric A. Branch0Joshua J. Cook1Achraf Cohen2Hillary Plummer3Alireza Emami4Jessica Truett5Adam W. Anz6Andrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USAAndrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USADepartment of Mathematics and Statistics, University of West Florida, Pensacola, FL, USAAndrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USAAndrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USAAndrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USAAndrews Institute Center for Regenerative Medicine, Department of Research, Andrews Research & Education Foundation, Gulf Breeze, FL, USA; Adam W. Anz, Andrews Research & Education Foundation, 1020 Gulf Breeze Pkwy, Gulf Breeze, FL 32561.Introduction: Autologous platelet-rich plasma (PRP) and hyaluronic acid (HA) are common treatments for knee osteoarthritis (OA). Several studies have demonstrated PRP as a safe and effective treatment for OA and, in some studies, produces a better outcome than HA. Objective: The primary objective of this study was to determine if HA injected with PRP would improve the efficacy of treatment of symptomatic knee OA compared to PRP alone. We hypothesized that the addition of HA would improve the efficacy of (PRP). Methods: A total of 64 participants with Kellgren-Lawrence (KL) Grades 1 to 4 knee OA were randomized into 2 groups and scheduled to receive 3-injections. Group 1 [PRP] received injections of PRP. Group 2 [HA+PRP] received the same treatment, with an additional HA injection for the first 2 injections. Both groups were blindfolded for the first 2 injections. To evaluate the efficacy of the regimen, participants completed patient reported outcome measures (PROMs). PROMs were completed prior to injections and at 1, 3, 6, 12, 18, and 24 months after the final injection. Results: Participants in both groups felt pain consistent with standard-of-care HA injection regimens with no difference in perceived pain. No infections or complications were observed. All PROM scores demonstrated improvement over baseline from 1-24 months post injections. There were no statistically significant differences between the groups. Conclusions: For the treatment of OA, PRP alone or PRP concomitantly with HA performed similarly out to 24 months. PRP in combination with HA was not superior to PRP alone.http://www.sciencedirect.com/science/article/pii/S2667254523000343ChondrodegenerationHyaluronic acidInflammatory biomarkersKnee osteoarthritisPlatelet-rich plasmaViscosupplementation
spellingShingle Eric A. Branch
Joshua J. Cook
Achraf Cohen
Hillary Plummer
Alireza Emami
Jessica Truett
Adam W. Anz
Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
Journal of Cartilage & Joint Preservation
Chondrodegeneration
Hyaluronic acid
Inflammatory biomarkers
Knee osteoarthritis
Platelet-rich plasma
Viscosupplementation
title Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
title_full Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
title_fullStr Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
title_full_unstemmed Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
title_short Platelet-rich plasma is similar to platelet-rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years: a randomized controlled trial
title_sort platelet rich plasma is similar to platelet rich plasma plus hyaluronic acid for the treatment of knee osteoarthritis at 2 years a randomized controlled trial
topic Chondrodegeneration
Hyaluronic acid
Inflammatory biomarkers
Knee osteoarthritis
Platelet-rich plasma
Viscosupplementation
url http://www.sciencedirect.com/science/article/pii/S2667254523000343
work_keys_str_mv AT ericabranch plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT joshuajcook plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT achrafcohen plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT hillaryplummer plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT alirezaemami plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT jessicatruett plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial
AT adamwanz plateletrichplasmaissimilartoplateletrichplasmaplushyaluronicacidforthetreatmentofkneeosteoarthritisat2yearsarandomizedcontrolledtrial